Catalyst overview
Research summary
This catalyst tracks a Phase 1 data readout for SRK-439 in Obesity. The expected timing is based on the latest available company guidance and may change.
6/24/24- New preclinical data at ADA '24. 11/4/24- Preclinical data at ObesityWeek '24. 8/6/25- File IND application in H2 2025. 11/14/25:- IND cleared; Ph1 HV dosing expected Q4 2025. 01/12/26:- Ph1 HV dosing ongoing; topline data in H2 2026. 03/03/26:- Phase 1 healthy volunteer dosing ongoing; topline data still expected in H2 2026. 05/07/26:- Phase 1 HV study ongoing; topline data still expected in H2 2026. 08/06/26:- Phase 1 study progressing; topline data still expected in Late 2026.
Verification
Confirm timing and program details against the company announcement or filing.